# Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

> **NCT07514962** · — · RECRUITING · sponsor: **Cardiocentro Ticino** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Artery Disease
- Antiplatelet Therapy
- Minimally Invasive Coronary Revascularization Surgery

## Interventions

- **PROCEDURE:** Cangrelor-guided MIDCAB surgery (for the prospective cases)
- **PROCEDURE:** Aspirin MIDCAB surgery (for the historical controls)

## Key facts

- **NCT ID:** NCT07514962
- **Lead sponsor:** Cardiocentro Ticino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-12
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514962, "Minimally Invasive Coronary Artery Bypass Supported by Cangrelor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07514962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*